Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc. Earnings Recaps

VREOF Health Care 3 recaps
Next earnings: March 24, 2027 (estimated) · full calendar
Q3 2026 Nov 11, 2026

Vireo reported Q3 revenue of $253.7 million and adjusted EBITDA of $42.7 million, alongside new quarterly outlook ranges as acquisitions expand the business. The stock fell 1.2%, a roughly flat reaction; cannabis retail growth was 4% pro forma year over year, while management cited seasonality as a factor in its Q4 outlook.

Key takeaways
  • Q3 GAAP revenue rose 177% year over year to $253.7 million; pro forma revenue was $277 million, including specified acquisitions as if completed July 1.
  • Adjusted EBITDA was approximately $42.7 million, up $17.3 million, or 68.1%, from a year earlier. Operating income improved by $13.9 million sequentially.
  • Pro forma cannabis retail revenue grew 4% year over year.
  • Q4 outlook is revenue of $250 million–$265 million and adjusted EBITDA of $45 million–$48 million, excluding pending acquisitions. Management cited an expected seasonal decline in the non-cannabis business.
  • The company ended the quarter with $106.8 million in cash and $293 million in long-term debt; it also announced a $60 million real estate term loan at a fixed 8.5% rate after quarter-end.
Q2 2026 Aug 13, 2026

The stock rose 4.3% on the back of Vireo’s significant revenue growth and scale expansion, driven by transformative acquisitions that broadened its multi-state footprint and diversified its platform beyond traditional cannabis operations.

Key takeaways
  • Q2 GAAP revenue grew 335% year-over-year to $209.3 million, reflecting rapid top-line expansion.
  • Pro forma revenue, incorporating recent acquisitions as if closed on April 1, reached $254.9 million, surpassing a $1 billion annualized run rate.
  • Cannabis segment revenue alone climbed 265% year-over-year to $175.8 million.
  • Non-cannabis businesses contributed $33.5 million, highlighting diversification into ancillary agribusiness.
  • Ongoing and announced acquisitions (FLUENT, C21, Planet 13, Ohio assets) will increase store count from 170 to ~270 across 15 states, enhancing market reach and operational scale.
Q1 2026 May 13, 2026

Vireo Growth’s shares rose modestly by 0.8% following Q1 results which showed steady pro forma revenue growth and margin improvements, but market reaction suggests investors are waiting for more decisive progress on integration and operational execution before rewarding the stock more fully.

Key takeaways
  • Reported GAAP revenue surged 333% year-over-year to $106.2 million, driven by multiple acquisitions closed in recent months.
  • Pro forma revenue, which includes all acquisitions as if they occurred on January 1, 2026, grew 5% year-over-year to $210.2 million, reflecting moderate organic growth in integrated markets.
  • Adjusted EBITDA on a pro forma basis increased 29.8% to $42.2 million, with margin expansion to 20.1% of sales from 16.2% last year.
  • Gross margin, excluding non-cash inventory fair value adjustments, improved by 280 basis points to 56.3%.
  • Company ended Q1 with a strong cash position of $137.8 million and $240 million in current assets versus $82 million in current liabilities, supporting ongoing M&A and investment plans.